FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Certificates

FDA
Registration Date 16 Nov 2016
Share

Xalkori

Medicine Pharmaceuticals Product Number : 0069-8140-20

Antineoplastic Agent

Drug Information

Generic
CRIZOTINIB
NDC Code
0069-8140-20
Drug Class
Multikinase inhibitors
Therapeutic Class
Antineoplastic Agent
Dosage form
Capsule
Route of Administration
Oral
Therapeutic Area
1.metastatic (cancer that has already spread) non-small cell lung cancer

Indication

XALKORI is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is caused by a defect in either a gene called ALK (anaplastic lymphoma kinase) or a gene called ROS1. It is not known if XALKORI is safe and effective in children.